United States Spinal Cord Injury, Muscular Dystrophy and Stroke

The goal of the first phase of the BrainGate clinical study is to demonstrate the System's ability to reliably record the participants' neural activity and translate their thoughts directly into a computer control signal. In other words, the study will determine the potential of the BrainGate System to give the study participants the ability to control a computer cursor using their thoughts.

Individuals with severe motor impairments from spinal cord injury, muscular dystrophy or stroke are being recruited into a clinical study. In addition to those with quadriplegia, the trial is also open to those with some movement in the upper body, as well as those who are non-speaking, or “locked-in.” Clinical trial participants must be permanent residents who live within a two hour drive of a study center. Final eligibility for participation in the clinical study is determined by the Principal Investigators, who are licensed Medical Doctors.

Enrollment in the pilot trial is now ongoing at rehabilitation centers located in Boston, Chicago and Providence. Additional sites may become available in the future.

View a BrainGate System educational animation by clicking here.